title: Specific inhibition of HIV-1 protease by boronated porphyrins.
authors.affiliation: Department of Pharmaceutical Chemistry, School of Pharmacy, University of California, San Francisco 94143-0446.
authors.forename: D L
authors.initials: DL
authors.lastname: DeCamp
authors.forename: L M
authors.initials: LM
authors.lastname: Babé
authors.forename: R
authors.initials: R
authors.lastname: Salto
authors.forename: J L
authors.initials: JL
authors.lastname: Lucich
authors.forename: M S
authors.initials: MS
authors.lastname: Koo
authors.forename: S B
authors.initials: SB
authors.lastname: Kahl
authors.forename: C S
authors.initials: CS
authors.lastname: Craik
mesh_terms: D016282:Aspartic Acid Endopeptidases / Q000037:antagonists & inhibitors; D001895:Boron / Q000494:pharmacology; D016333:HIV Protease; D015497:HIV-1 / Q000187:drug effects / Q000201:enzymology*; D011166:Porphyrins / Q000494:pharmacology*; D011480:Protease Inhibitors / Q000494:pharmacology*; D013329:Structure-Activity Relationship
chemical_list: D011166:Porphyrins; D011480:Protease Inhibitors; D016282:Aspartic Acid Endopeptidases; D016333:HIV Protease; C065184:p16 protease, Human immunodeficiency virus 2; D001895:Boron